HDA UK Media And Political Bulletin – 23 May 2017

Media Summary

Assessment of medicine scanning law delayed by election
Chemist and Druggist, Tom Cox, 22 May 2017

Martin Sawer, HDA Executive Director, told C+D at last week’s HDA Annual Conference that he hopes the delayed impact assessment and a public consultation of the scanning law will be published over the summer. He explained that the government’s impact assessment of placing medicine scanners in every pharmacy has been delayed by the general election. The video interview of Martin Sawer discussing FMD and the impact on pharmacy is available to watch here.

Announcement of the EMA Management Board: Confirmation of full functionality of the EudraVigilance database
European Medicines Agency, 22 May 2017

The European Medicines Agency (EMA) in collaboration with the Member States and the Commission, drew up the functional specifications for the EudraVigilance database – the system for managing information on suspected adverse reactions to medicines. After consideration of an independent audit report and the Pharmacovigilance Risk Assessment Committee (PRAC) recommendation, the EMA Management Board has confirmed that the EudraVigilance database has achieved full functionality and the system meets the functional specifications.

Parliamentary Coverage

There is no Parliamentary Coverage.

Full Coverage

Assessment of medicine scanning law delayed by election
Chemist and Druggist, Tom Cox, 23 May 2017

The government’s impact assessment of placing medicine scanners in every pharmacy has been delayed by the general election, according to the Healthcare Distribution Association (HDA).

Under the falsified medicines directive (FMD), all community pharmacies in the UK will have to scan medicines at the point of dispensing by February 2019, as part of European anti-counterfeiting measures.

Speaking at the HDA’s annual conference last week (May 18), chief executive Martin Sawer told C+D he hopes the delayed impact assessment and a public consultation of the scanning law will be published over the summer.

“Some of the movements in pharmacy” would have to be decided by the General Pharmaceutical Council and the Medicines and Healthcare products Regulatory Agency, once the government publishes its delayed consultation, he added.

Watch the video below to see more from Mr Sawer, including his explanation of why the FMD is coming into force.

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?